APOLLOMICS INC

Watch

Share

APLM·G0411D123·US·Common Stock·Healthcare - Biotechnology-Activist

APLM (APOLLOMICS INC) is held by 3 institutional investors as of Q1 2026. Largest holders: CITIGROUP INC ($6,811), UBS Group AG ($2,251), BlackRock, Inc. ($16). Net institutional sentiment: Mixed.

3

Holders

Avg rating

$9,078

Total Value

67% (4)

Fund Consensus

2 buying - 1 selling

Smart Money Verdict

View all

Institutional (13F)

Insider (Form 4)

Activist (13D/13G)

Congressional (STOCK Act)

Holder Quality

★★★★★

Elite

★★★★

Strong

★★★

Solid

★★

Below

★

Weak

Held by 3 funds

Who's Trading

ActivistYCYi-Kuei Chen5.3%Apr 8, 2026

ActivistHCHung-Wen Chen41.8%Apr 6, 2026

ActivistMIMaxpro Investment Co., Ltd4.9%Sep 5, 2025

View all activist filings

13F: Mar 31, 2026Insider & Congress: Updated regularly

Positions (3)History

AllNewIncreasedHeldDecreasedExited

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
CITIGROUP INC	New	438	$6,811	0.0%	-4.29%	24
UBS Group AG	Increased	142(+121.9%)	$2,251	0.0%	+1.58%	13
BlackRock, Inc.	Unchanged	1	$16	0.0%	+87.07%	0
Kestra Advisory Services, LLC	Exited	0(-100.0%)	$81,884	0.0%	-4.26%	0

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

413 holders · $666.6B

UNHUNITEDHEALTH GROUP INC

413 holders · $186.3B

JNJJOHNSON & JOHNSON

394 holders · $391.3B

DHRDANAHER CORP DEL

392 holders · $97B

ISRGINTUITIVE SURGICAL INC

391 holders · $123.5B

TMOTHERMO FISHER SCIENTIFIC INC

391 holders · $147B

BSXBOSTON SCIENTIFIC CORP

389 holders · $76.8B

MRKMERCK & CO INC

385 holders · $208.9B

ABBVABBVIE INC

381 holders · $254.9B

ABTABBOTT LABORATORIES

380 holders · $129.1B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer